CompletedNot Applicable

Diaphragmatic Thickness and Pulmonary Function in Parkinson's Disease

Turkey (Türkiye)37 participantsStarted 2021-12-24

Plain-language summary

Ultrasound can give important information about the morphology of the diaphragm and the amount of contraction. Our aim, with the prediction that a restrictive pathology will occur in the pulmonary function with the addition of camptocormia in Parkinson's patients; to compare respiratory functions in Parkinson's patients with and without camptocormia, to investigate the correlation between ultrasonographically measured diaphragmatic thickness and pulmonary function test values.

Who can participate

Age range40 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being diagnosed with Parkinson's * Volunteer to participate in the study Exclusion Criteria: * Being in contact with or suffering from COVID-19 * Having diseases that increase intra-abdominal pressure and venous insufficiency * Having diseases that affect diaphragmatic motility * Have had recent thoracic or abdominal surgery * Having a parenchymal, pleural, or chest wall mass that may cause restriction on a recent chest X-ray or CT

What they're measuring

Pulmonary function test

Timeframe: 1 hour

Ultrasonography

Timeframe: 1 hour

Trial details

NCT IDNCT05194748

SponsorAbant Izzet Baysal University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-01-01

View on ClinicalTrials.gov More Parkinson's Disease and Parkinsonism trials